These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9883441)

  • 1. Partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon alpha 2a.
    Wollina U
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):261-2. PubMed ID: 9883441
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma.
    Fimiani M; Rubegni P; De Aloe G; Andreassi L
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):502-3. PubMed ID: 10459134
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: a retrospective single-center analysis.
    Wollina U; Liebold K; Kaatz M; Looks A; Stuhlert A; Lange D
    Ann N Y Acad Sci; 2001 Sep; 941():217-9. PubMed ID: 11594578
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment.
    Altomare G; Capella GL; Frigerio E
    Acta Derm Venereol; 1998 Mar; 78(2):159. PubMed ID: 9534907
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma.
    Zachariae H; Thestrup-Pedersen K
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of non-AIDS Kaposi sarcoma during therapy with interferon alfa-2a in an 82-year-old man with concomitant cutaneous T-cell lymphoma.
    Giuliani M; Mastroianni A; Di Carlo A; Donati P; Miceli M; Monini P; Rezza G
    Arch Dermatol; 2002 Apr; 138(4):535-7. PubMed ID: 11939825
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon alpha in the treatment of cutaneous T-cell lymphoma].
    Dréno B
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S27-30. PubMed ID: 16385896
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alpha 2a and etretinate.
    Dréno B; Claudy A; Meynadier J; Verret JL; Souteyrand P; Ortonne JP; Kalis B; Godefroy WY; Beerblock K; Thill L
    Br J Dermatol; 1991 Nov; 125(5):456-9. PubMed ID: 1751352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of childhood cutaneous T-cell lymphoma with alpha-interferon plus PUVA.
    Tay YK; Weston WL; Aeling JL
    Pediatr Dermatol; 1996; 13(6):496-500. PubMed ID: 8987062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatment for cutaneous lymphomas.
    Mielke V; Staib G; Sterry W
    Recent Results Cancer Res; 1995; 139():403-8. PubMed ID: 7597307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma.
    Chiarion-Sileni V; Bononi A; Fornasa CV; Soraru M; Alaibac M; Ferrazzi E; Redelotti R; Peserico A; Monfardini S; Salvagno L
    Cancer; 2002 Aug; 95(3):569-75. PubMed ID: 12209749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma.
    Schiller M; Tsianakas A; Sterry W; Dummer R; Hinke A; Nashan D; Stadler R
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1841-1847. PubMed ID: 28557110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
    Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
    Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous B-cell lymphoma: treatment with low dose intralesional recombinant interferon-alpha 2A.
    Rubegni P; De Aloe G; Pianigiani E; Lazzi S; Fimiani M
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):70-1. PubMed ID: 10188159
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
    Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
    Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.
    Tracey L; Villuendas R; Ortiz P; Dopazo A; Spiteri I; Lombardia L; Rodríguez-Peralto JL; Fernández-Herrera J; Hernández A; Fraga J; Dominguez O; Herrero J; Alonso MA; Dopazo J; Piris MA
    Am J Pathol; 2002 Nov; 161(5):1825-37. PubMed ID: 12414529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.